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Abstract
Background Hemodialysis (HD) in children with a concomi-
tant ventriculoperitoneal shunt (VPS) is rare. Registry data
suggest that peritoneal dialysis with a VPS is safe, but little
is known about HD in the presence of a VPS.
Methods We performed a 10-year survey to determine the
prevalence of a VPS, complications and outcome in children
with a VPS on HD in 15 dialysis units from the 13 countries
participating in the European Pediatric Dialysis Working
Group.
Results Eleven cases of HD with a VPS were reported (prev-
alence 1.33 %; 328 patient-months) and compared with pro-
spective Registry data. The median age at start of dialysis was
9.6 [inter-quartile range (IQR) 1.0–15.0] years and median
HD vintage was 2.4 (IQR 1.7–3.0) years. Dialysis was per-
formed through a central venous line (CVL) and through an
arteriovenous fistula in six and five children, respectively.
Three CVL infections occurred in two children, but these chil-
dren did not develop VPS infections or meningitis. Symptoms
of hemodynamic instability were reported in six (55 %) chil-
dren at least once per week, with hypotension or hypertension
occurring in four of these children and nausea, vomiting and
headaches occurring in two; four other children reported less
frequent symptoms. Seizures on dialysis occurred in two chil-
dren, at a frequency of less than once per month, with one
child also experiencing visual disturbances. During follow-
up (median 4.0; IQR 0.38–7.63 years), three children
remained on HD and eight had a functioning transplant. No
patients were switched to PD.
Conclusions Hemodialysis in children with a VPS is safe, but
associated with frequent symptoms of hemodynamic instabil-
ity. No episodes of VPS infection or meningitis were seen
among the children in the survey, not even in those with
CVL sepsis.
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Introduction
Dialysis in children with concomitant ventriculoperitoneal
shunts (VPS) is uncommon, with only anecdotal reports in
the literature, both in adults [1] and children [2, 3]. The poten-
tial for developing shunt infections is increased in children on
hemodialysis (HD), who also show a poor tolerance of dialy-
sis due to the possibility of fluid shifts induced during a HD
session leading to abrupt changes in the intracerebral pressure.
There is a single case report of an adult on HDwho developed
VPS-associated sepsis [4]. Similarly, children with VPS on
peritoneal dialysis (PD) are thought to be at risk of shunt
infection, and the presence of a ‘foreign body’ in the perito-
neal cavity is considered to be a contraindication for PD by
many nephrologists. However, a recent survey from the Inter-
national Pediatric Peritoneal Dialysis Network (IPPDN) found
no evidence to support an increased risk of peritonitis or VPS
infection in children on PD [5].
We conducted a 10-year survey across 15 pediatric dialysis
centers from the 13 European Union countries that represent
the European Pediatric Dialysis Working Group (EPDWG) to
review the prevalence, safety, complications and outcome of
HD in children with VPS.
Subjects and methods
All children with VPS receiving HD or hemodiafiltration
(HDF) in 15 European pediatric nephrology centers between
April 2004 and March 2014 were included in the survey. Pa-
tients were identified from recall and checked against the di-
alysis database maintained in each unit. Anonymized retro-
spective data collection was performed via questionnaires dis-
tributed to all 15 centers represented in the EPDWG. Informa-
tion on the demographics of the chronic HD population in
each center was collected, together with additional detailed
information on patient characteristics, specifics of the HD
therapy, management of complications and outcome for each
child with a VPS on HD. Hemodynamic instability was de-
fined for this survey as hypotension, hypertension, nausea,
vomiting, headaches, visual disturbances or seizures. Data
were submitted to a central unit for analysis (Great Ormond
Street Hospital, London) and verified by email correspon-
dence and at meetings of the group. Ethical approval for ret-
rospective case-note review was obtained as per local require-
ments. For comparison, episodes of symptomatic hemody-
namic instability were recorded in a cohort of children on
HD who did not have VPS matched for age, gender and dial-
ysis vintage. Data from children dialyzed contemporaneously
to our study cohort were not available, so we collected details
from the International Pediatric Hemodialysis Network
(IPHN; http://www.pedpd.org/), an international registry of
pediatric HD patients that maintains a prospective database
on dialysis technique, outcomes and management.
Shunt characteristics
All shunts were inserted prior to the commencement of dialy-
sis. Shunt position was ventriculoperitoneal in ten children
and ventriculoatrial (VA) in one child. One VPS was later
changed to a VA shunt 6 months after the commencement of
HDF due tomalfunction. The shunts were inserted at a median
age of 6 months [interquartile range (IQR) 1 day–12 months].
Five children (45 %) had their shunts revised 11 times in total.
On ten occasions this was for shunt malfunction and took
place before dialysis was commenced. One child had the shunt
externalized as a precaution following a renal transplantation
that was complicated by acute appendicitis and candida
wound infection with graft failure and a return to HD within
8 days.
Dialysis prescriptions
Nine children were on HD as the predominant dialysis modal-
ity and two were on HDF. It was not possible to compare
modalities due to the small numbers of patients. All HD ses-
sions were performed three times a week, for 4 h per session.
Two children were started on HDF from the outset, with three
to five sessions per week, for 3–4 h per session. The dialysis
modality and duration followed unit policy and was not
changed in those with a VPS.
Dialysate prescriptions varied between centers. The medi-
an dialysate sodium and bicarbonate level was 140 (IQR 138–
143) and 34 (IQR 32–35) mMol/l, respectively. The median
dialysate temperature was 36.5 (IQR 36–37) °C. All but one
center used a glucose-containing dialysate. Sodium and ultra-
filtration profiling was routinely performed in two centers (1
patient each).
Statistical analysis
Since most data were non-parametric, the results are presented
as the median and IQR. Due to the small number of patients
only descriptive statistics were possible.
Results
During the study period there were 11 children with VPS on
HD distributed across eight of the 15 centers representing the
EPDWG. Three centers were treating two children each and
five centers were treating one child each. During the 10-year
study period 824 children received HD. The prevalence of HD
patients with a VPS was 1.33 %, with 322 patient-months
experience of HD in children with a VPS.
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Patient characteristics are presented in Table 1. The median
age at start of dialysis was 9.6 (IQR 6–13) years. The median
time on dialysis with a VPS was 2.4 (IQR 1.7–3.0) years.
Seven (64 %) patients had residual renal function when HD
was first started; of these, one subsequently became anuric and
one with focal segmental glomerulosclerosis had bilateral ne-
phrectomies. The two children with VA shunts both had an
arteriovenous fistula (AVF), formed in the non-dominant
hand, which was also contralateral to the VA shunt. All central
venous lines (CVLs) were in the internal jugular or
brachiocephalic veins. All access was achieved using the
double-lumen or double-needle technique. No child had ever
received PD, and no patient had switched to PD as a result of
symptoms.
Complications of dialysis
Infections Three CVL infections were reported in two chil-
dren (18 %). The causal organisms were methicillin-resistant
Staphylococcus aureus, Staphylococcus haemolyticus and
Streptococcus in one case each. None of the CVL infections
led to VPS infection or meningitis. There were no cases of
primary VPS infection or meningitis in any child once
established on HD. One child had the VPS temporarily exter-
nalized as a precautionary measure to minimize the risk of an
ascending Candida infection following a traumatic renal
transplantation complicated by appendicitis and an infected
surgical wound; no infection occurred.
Hemodynamic complications Of the 11 children included in
the survey, six (55 %) had symptoms of hemodynamic insta-
bility as described in detail in Table 1. Five of the six children
with frequent symptoms had a residual urine output, but one
child continued to experience symptoms following bilateral
nephrectomies. The three children who were anuric experi-
enced minimal or no symptoms. In a limited number of pa-
tients there was no correlation between the ultrafiltration vol-
ume per session and hemodynamic complications, but a com-
plete set of data was not available for all patients. The two
children who were started on HDF from the outset (and were
also anuric) had the fewest symptoms. The frequency of
symptoms is described in Table 2.
Seizures and visual disturbances Two children (18 %) on
dialysis experienced seizures, both of whom had been diag-
nosed with epilepsy prior to commencement of dialysis. Both
had seizures at a frequency of less than once per month. One
child, who had an underlying diagnosis of hydrocephalus and
focal segmental glomerulosclerosis but no other abnormalities
on cranial computed tomography imaging, was known to have
tonic/clonic seizures of short duration that were triggered by
intercurrent illness even prior to the commencement of dialy-
sis and was treated with carbamazepine. Two seizures
occurred in this child during HD, both lasting <5 min and
resolving spontaneously. The carbamazepine dose was in-
creased, and no further seizures were noted. This child also
had occasional visual disturbances that were associated with
intradialytic hypotension that occurred infrequently (less than
once a month).
The second child, who had meningomyelocele but no other
abnormalities on cranial magnetic resonance imaging scan,
had short-lasting and self-resolving tonic–clonic seizures on
dialysis that were thought to be triggered by fluid shifts during
dialysis. No response was seen with mannitol or anti-epileptic
treatment. In both cases the seizures were not attributed to
shunt dysfunction or shunt infection.
For comparison, data from IPHN showed that four of 43
(9 %) children dialyzed in our centers developed infrequent
complications of nausea or headaches and that two others
(4.6 %) had frequent headaches over a median study duration
of 6 months.
Management of dialysis complications
Three children (27 %) were switched from HD to HDF in an
attempt to achieve better control of their fluid status. This
change was reported to have reduced the frequency of
intradialytic hypotensive episodes in two of the children. For
the two children who demonstrated frequent intradialytic
complications (nausea, vomiting and headache at least once
a week), the dialysis session was increased from 4 to 5 h in one
child and to up to 8 h in the other child; however, in both cases
the symptoms continued to occur. The dialysate temperature
was reduced in two children. Dialysate sodium was altered in
three cases, with sodium profiling in one case, but this was
abandoned as it proved to be ineffective. No child was
switched to daily dialysis sessions.
Intradialytic complications were most commonly
managed by adjusting the ultrafiltration rate as the first
step: ultrafiltration was temporarily stopped in eight
(73 %) children, with three (27 %) children requiring
a decrease in the total ultrafiltration volume and seven
children (64 %) requiring the administration of a saline
bolus. Three (27 %) children frequently required early
discontinuation of the dialysis session. One child re-
quired prophylactic mannitol during each dialysis ses-
sion, and in another child mannitol was used when
symptoms of hypotension developed.
Outcome
At final follow-up after a median of 4.0 (IQR 0.38–7.63)
years, eight children have a functioning transplant and three
remain on HD. No child converted from HD to PD during the
study period. There were no deaths.
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Discussion
In this 10-year survey across 15 pediatric dialysis units in
Europe we have shown that HD in children with a VPS is
safe, with no VPS infection or meningitis even in those with
dialysis catheter infections. However, our survey suggests that
HD in the presence of a VPS is associated with frequent symp-
toms of hemodynamic instability and seizures, making the
dialysis therapy more complicated to manage and difficult
for the child to tolerate.
There is little known about dialysis in the presence of a
VPS, either in adults or children. The number of children with
VPS requiring chronic dialysis is very low, with 18 cases of
PD (prevalence 0.6 %) [5] and 11 cases of HD (prevalence
1.33 %) in children with a VPS in our survey. The decision to
start HD a child with a VPS or a VA shunt is significant and
usually subject to medical discussion regarding the selection
of treatment modality. In our survey each center had carefully
searched through their HD databases in order to correctly
identify all patients with a VPS. According to a recent survey
from the IPPDN, PD in the presence of a VPS is safe, with no
increase in the risk of either VPS infections or peritonitis [5].
Our survey is the first report on the safety and feasibility of
HD in children with a VPS based on a multicenter survey.
There are concerns about performing dialysis in patients
with a VPS due to the risk of cross-infections between the
dialysis catheter and the VPS or a risk of ascending infection
from the peritoneum. However, a study performed 25 years
ago demonstrated that PDwith a VPS is feasible [6]. In a study
of peritonitis rates in children with spina bifida on PD, four
episodes of peritonitis were reported in three children with a
VPS, but none of the children developed concomitant VPS
infection [3]. The IPPDNRegistry reports 20 episodes of peri-
tonitis in 11 of 18 children on PD with a VPS, giving a peri-
tonitis rate of 1 in 19.6 patient-months [5]. The Registry re-
ported no ascending infections associated with peritonitis al-
though there were 20 peritonitis episodes recorded during the
study period. One child developed a shunt infection, but this
was in the absence of peritonitis. Four children were trans-
ferred to HD, but the change in dialysis modality was not
due to a VPS-related malfunction or infection.
There is a single report of VPS-associated sepsis in a pa-
tient on HD. This was a case of coagulase-negative
Staphylococcus VPS infection in an adult on HD dialyzed
via an AVF [4]. Diagnosis was confirmed by lumbar puncture
and the culture of free fluid sampled in the peritoneum; all
blood cultures remained sterile, although the patient had
spikes of fever during dialysis. The patient had been on HD
for 5 years with the VPS in situ before the start of HD and was
successfully treated and continued on HD. There is a second
report of an iatrogenic VPS infection following insertion of an
HD catheter which resulted in traumatic damage to the shunt
with cerebrospinal fluid (CSF) leakage [7]. Our survey iden-
tified three HD line infections, but none resulted in ascending
infection of the shunt.
The majority of children in our survey had symptoms of
hemodynamic instability on dialysis. Three children (27 %)
were switched fromHD toHDF in an attempt to achieve better
control of their fluid status. This change in dialysis modality
was reported to have reduced the frequency of intradialytic
symptoms in two children, but these were not children who
experienced frequent symptoms. Intradialytic hypotension is a
common complication of dialysis, and reported rates in adults
range from 17 to 31 % [8, 9]; there are no comparable data in
children [10]. We found a significantly lower prevalence of
hypotensive complications in children without VP shunts.
Acute reductions in myocardial blood flow (myocardial stun-
ning) during conventional HD which correlate with
intradialytic blood changes and ultrafiltration volume have
been demonstrated in children [11]. The typical management
of intradialytic hypotension is to either reduce or stop ultrafil-
tration, administer a bolus of saline or discontinue the session
prematurely [10]. These responses had little effect in control-
ling the symptoms of the affected patients in our survey.
Table 2 Symptoms of
hemodynamic instability reported
by the children with a
ventriculoperitoneal shunt (VPS)
on hemodialysis (n = 11)
Symptoms experienced Number of children experiencing symptoms and frquency of symptomsa
Every session/at least
weekly
<Once a week <Once a month/infrequent Never
Hypotension 2 1 4 4
Hypertension 2 2 2 5
Visual disturbances 0 0 1 10
Nausea 2 1 1 7
Vomiting 2 3 1 5
Headache 2 1 4 4
Seizures 0 0 2 9
a Respondents were asked to rate symptom frequency as ‘every session’/‘once a week’, ‘less than once a week’,
‘less than once a month’ or ‘never’
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Despite the frequency of symptoms, no child was switched to
PD. There are no reports of hemodynamic instability in chil-
dren with a VPS receiving PD to allow for comparison with
those receiving HD or HDF.
Hemodiafiltration has been shown to reduce intradialytic
hypotension. In a randomized controlled trial of adults on HD,
HDF and hemofiltration, intradialytic symptomatic hypoten-
sion was recorded in 7.5 % of sessions, with significantly
fewer episodes among patients on HDF compared to those
on HD [12]. Fewer symptoms of intradialytic hypotension in
patients treated with HDF compared with HD have also been
reported [13]. Daily 3-h HDF sessions six times per week
have been shown to be more effacious than daily 4-h HDF
sessions three times a week, with a reduction in blood pres-
sure, improvement in left ventricular size and function, an
enhanced feeling of general well-being and no post-dialysis
recovery time [14, 15]. No center participating in our survey
reported increasing the hours of daily dialysis to alleviate the
symptoms of hemodynamic instability.
The use of prophylactic mannitol, an osmotic agent, has
been reported to half the odds of intradialytic symptoms and
increase tolerance to ultrafiltration [16]. Mannitol was used in
two of the children in our survey, but it did not improve symp-
toms. The secretion of CSF is variable, with adults producing
as much as 750 ml a day [17]. The child in our study who had
the VPS externalized demonstrated variation in drainage: dur-
ing HD the shunt drained approximately 300 ml over 4 h,
whereas the same volume was drained over 24 h when the
child was off dialysis (personal observation). Fluid shifts dur-
ing dialysis, in particular the very rapid movement of CSF,
may account for the hemodynamic instability seen in some
children on dialysis.
Regardless of dialysis modality, the VPS is susceptible to a
range of complications, including mechanical blockage, valve
failure, disconnection and infection [18]. The authors of a
longitudinal study of VPS in adults and children reported sur-
gical shunt complications in 35 % of the patients over a mean
follow-up period of 4.5 years. Children, particularly neonates,
experienced the highest complication rates [19]: almost half of
the children required a repeated surgical procedure by 5 years
of follow-up. None of our patients developed a VPS-related
surgical complication despite a comparable follow-up period.
Encapsulating sclerosing peritonitis, which is most commonly
associated with chronic PD [20, 21], has also been reported in
two children with VP shunts who were not on dialysis [22].
Our study has a number of limitations common to many
multicenter retrospective surveys. Patients were identified by
recall and underreporting is possible but unlikely as HD in the
presence of a VPS is a significant management issue on a
pediatric dialysis unit. A prospective audit across all European
dialysis centers through Registry data would give a greater
perspective on the prevalence, dialysis management and com-
plications of children with a VPS on HD. Comparison with a
cohort of children without VPS would give a clear idea if the
reported hemodynamic instability was caused by the VPS or
due to fluid shifts that are seen in chronic HD patients. We
were unable to obtain data from children dialyzed during the
same study period as our study cohort, and the significantly
lower rate of hemodynamic complications in our current HD
patients without VP shunts may reflect improved dialysis
management.
In conclusion, our survey suggests that HD in children with
a VPS is a safe procedure, with no episodes of VPS infection
or meningitis even in those with CVL sepsis. However, an
increased frequency of hemodynamic instability can make
the dialysis therapy more complicated to manage and difficult
for the child to tolerate. As shown in studies with adult HD
patients, HDF may also decrease hemodynamic instability in
patients with VPS.
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